Article: VaxGen Responds to Media Report Regarding Proposed Congressional Investigation of Anthrax Vaccine Contract.

BRISBANE, Calif., April 5 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN.PK) issued the following statement today from its President and Chief Executive, Lance K. Gordon, Ph.D., in response to a proposed investigation into the company's anthrax vaccine contract by Congressman Mike Rogers (R-Mich.), which was reported in an Associated Press article.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )

"We were surprised by Congressman Rogers' call for an investigation of our Project BioShield anthrax vaccine contract, because:

 
   --  The Department of Health and Human Service's (HHS) award in November 
   2004 of a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!